Editorial: Mycobacterial Glycolipids—Role in Immunomodulation and Targets for Vaccine Development
Gunilla Källenius,
Jérôme Nigou,
Andrea Cooper,
Margarida Correia-Neves,
Margarida Correia-Neves,
Margarida Correia-Neves
Affiliations
Gunilla Källenius
Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
Jérôme Nigou
Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, Centre national de la recherche scientifique (CNRS), Université Paul Sabatier, Toulouse, France
Andrea Cooper
Leicester Tuberculosis Research Group (LTBRG), Department of Respiratory Sciences, University of Leicester, Leicester, United Kingdom
Margarida Correia-Neves
Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
Margarida Correia-Neves
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal
Margarida Correia-Neves
ICVS/Biomaterials, Biodegradables and Biomimetics (3B’s), Portugal (PT) Government Associate Laboratory, Braga, Portugal